Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If this is legit, then $3 seems pretty low. If not, $3 seems high unless something pans out, like their flavor of omega 3.
ATDS is such a nasty dog.
Are they using their free WordPress tools to make money?
Are they telling their free customers (via T&C) that they need to agree to some data collection in order to keep using their free software?
Are they advertising paid services to all of their free customers?
Are they collecting data (legally via T&C) from all of the websites that use their software, and selling it to third parties?
Are they partnering with other companies that don't have the same foothold that Data433 has, yet have products to sell?
I can't run Data433, I don't have the time, but if they really can't do it, they should consider contacting me or someone else with similar ideas for help.
People sold on the great news that came out. Interesting
That helped my search. Thank you.
They reportedly took a 6% stake
*pop*
I wonder what happened
But didn't AMRN lose their patent in the USA? They could use and develop MTNB's product with the cash they have on hand.
Why isn't AMRN buying MTNB? The combo could be huge for both companies. What am I missing? Thanks.
This stock is tough to comprehend
It's a private group
Obviously people have different opinions on that, and I can't says which is right
Let me come at it from the other direction, what happened 4 days ago to cause the stock to go down from what is was for most of May? The threat of covid coming back strong?
You didn't answer my question, about the stock price, and how it was higher just a week ago, when there was more risk.
The stock price a week ago was higher than it is now. With this settlement, is AMRN worth more or less than it was then?
Dr. Steve Nissen, a leading cardiologist at the Cleveland Clinic, broke some news this weekend about a "prescription fish oil" and 13,000 patient trial that he's working on. He mentioned his doubts, and said his group will be discussing this in more detail later this year. This may be critical information for any investors or patients.
The comments start at 56:09:
https://podcasts.google.com/feed/aHR0cHM6Ly93d3cucGVvcGxlc3BoYXJtYWN5LmNvbS9mZWVkL3BvZGNhc3Qv/episode/aHR0cHM6Ly93d3cucGVvcGxlc3BoYXJtYWN5LmNvbS8_cD0xMTI1ODImcHJldmlldz10cnVl?ved=0CAgQ38oDahcKEwiQiJLxv8vpAhUAAAAAHQAAAAAQAQ
Or
https://www.peoplespharmacy.com/articles/show-1213-how-does-covid-19-affect-your-heart
If you buy now, averaging down, you'll move your break even way down. That's one thing you control.
Surprise surprise
I bought your shares. They were free
A forgivable loan is especially nice.
Way up after hours. What's up?
Keep in mind that the Fed is trying to force stocks higher, using a flood of cash.
AMRN has been quite a ride. At $5, is Amerin a good business on to own?
So does Amarin have really good lawyers?
The price is down significantly after-hours, but are we sure that the regular session will respect the price from the after-hours sessions?
I can't know exactly what the volume will be tomorrow premarket, but the volume after-hours was pretty light, which means most of the investors/traders haven't spoken yet.
It's broken when health care resources go to towards people who get little exercise and eat the standard American diet, meanwhile people who care about themselves, eating right and exercising, don't get the health care dollars because their triglycerides are no longer over 150 due to previous lifestyle changes.
Insurance companies would rather pay hundreds of thousands for a heart surgery, then pay upfront to avoid surgery from happening. I don't know how you can say otherwise.
I've heard the same from many experts on statins, how they provide little value for healthy people, but provide great value after a cardiac event. It's those of us trying to head off a more than possible cardiac event that are looking for options.
There's no doubt that the health care system is broken.
Thank you for sharing your story.
What you experienced will push many to buy over the counter EPA, even when it's less pure than Vescepa, and require at least 3 pills per dose instead of 2.
This article fails to mention the prior authorization issue. The risk of growth being limited due to lack of insurance company support needs to be considered.
It's not as good as you think, you have to buy at the right time and sell at the right time. I bought right before it dropped, so then in a panic, I doubled down after it dropped. Once it came back up, I sold everything, just to break even. It's rare to buy right at the bottom and sell right at the top.
Customers don't have to be buyers. Customers are those that get/use a product.
"Can privacy be big business? A wave of startups thinks so.":
https://www.nbcnews.com/tech/security/can-privacy-be-big-business-wave-startups-thinks-so-n1128626
That didn't explain Friday. Lol
Why would they pay .35 if someone will sell for .32?
If you avoid buying, the price will go down, and I can buy some more cheap shares.
Even if you believe in power of technical analysis, TA doesn't control the price action, it just tries to predict it.
You're a good sport. I hope you got some shares too.
I wish I knew more about why it went up 70% today without any news.
I know I made some great points this weekend, explaining a path forward for this company to make it, but I didn't think many people were listening.
Actually it's a bounce backed up by money. The volume has been increasing too.
All stocks go up and down, that's how the market works.
You're the kind of trader I like trading with.
You're right, there are a lot of free solutions out there. That means my idea of D443 legally mining data from their free WordPress customers is just as important as I suggested it would be.
Who are D443 biggest competitors?
‘We have a huge problem’: European tech regulator despairs over lack of enforcement
https://www.politico.com/news/2019/12/27/europe-gdpr-technology-regulation-089605
EU Privacy Regulators Expected to Raise Fines Under GDPR Data Protection Rules
https://www.insurancejournal.com/news/international/2020/01/22/556075.htm
It's not Jason's fault that regulators have been slow to enforce GDPR.
https://www.cbronline.com/boardroom/policyregulation/gdpr-fines-survey/
https://www.cnbc.com/2020/01/19/eu-gdpr-privacy-law-led-to-over-100-million-in-fines.html
https://digiday.com/marketing/uk-regulator-warns-ad-tech-clean-act/
Some of the people complaining are frustrated, while others clearly are trying to drive the price lower so they can buy more, that's reality.
The fundamentals haven't changed. If you liked the business before, you should still like it now. And now the prices are cheaper.
People that only bought it before because other people were bidding the share price up, aren't happy because so many other people sold first.
Longs are buying right now.